Metoclopramida Accord

Metoclopramide, the active ingredient in Metoclopramida Accord, is a dopamine D2 receptor antagonist presented as an oral dosage form for systemic use. It is employed to control nausea, vomiting and to improve gastric motility in a variety of clinical settings. GNH USA supplies Metoclopramida Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic pathways that trigger nausea and delayed gastric emptying, making it useful for several gastrointestinal and postoperative conditions. - Nausea and vomiting: reduces the frequency and severity of acute and chronic episodes. - Post‑operative nausea and vomiting: helps prevent and treat nausea after surgery. - Gastroparesis: enhances gastric emptying and alleviates related symptoms. - Reflux disease: improves lower esophageal sphincter tone and reduces reflux episodes.

Metoclopramide may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness: mild sedation or fatigue. - Restlessness: feeling of inner tension or agitation. - Diarrhea: loose stools or increased bowel movements. - Headache: mild to moderate cranial pain. - Dry mouth: reduced salivation. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Cardiac arrhythmias: irregular heart rhythms. - Hyperprolactinemia: elevated prolactin causing galactorrhea or menstrual disturbances.

Before prescribing Metoclopramida Accord, clinicians should consider several safety factors. - History of movement disorders: avoid in patients with Parkinson's disease or prior extrapyramidal reactions. - Renal impairment: dose adjustment may be required for reduced clearance. - Elderly patients: monitor closely for confusion or sedation. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Concomitant CNS depressants: may enhance drowsiness or dizziness. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Metoclopramide can influence the activity of several other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine antagonism may increase extrapyramidal risk. - MAO inhibitors: combined use can precipitate hypertensive crises. - CYP2D6 substrates (e.g., codeine): metoclopramide may inhibit metabolism, raising plasma levels.

Moderate Interactions (Monitor Closely): - Opioids: enhanced nausea or sedation. - Anticholinergic agents: may counteract pro‑kinetic effects. - SSRIs or SNRIs: potential for serotonin syndrome when combined with serotonergic activity. - Digoxin: possible increase in serum concentration. - Corticosteroids: may augment risk of hyperprolactinemia.